What is Pacira BioSciences, Inc.'s revenue?

Pacira BioSciences, Inc. (PCRX) generated $734.9M in revenue over the trailing twelve months, up 4.6% year over year.

Is Pacira BioSciences, Inc. profitable?

Pacira BioSciences, Inc. reported $5.1M in net income over the trailing twelve months, a 0.7% net margin.

What are Pacira BioSciences, Inc.'s profit margins?

Gross margin is 79.3% and operating margin is 3.3%, with a 0.7% net margin.

What is Pacira BioSciences, Inc.'s earnings per share?

Pacira BioSciences, Inc.'s diluted EPS over the trailing twelve months is $0.12.

Where does Pacira BioSciences, Inc.'s income statement data come from?

Every line is extracted from Pacira BioSciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Pacira BioSciences, Inc. PCRX Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Total revenue	$734.86M+4.6%	$726.41M+3.6%	$716.79M+3.1%	$705.85M+2.3%	$702.77M+3.1%
Total cost of revenue	$151.86M-3.5%	$149.75M-12.1%	$149.34M-16.2%	$153.92M-14.1%	$157.32M-14.1%
Gross profit	$583.01M+6.9%	$576.66M+8.7%	$567.46M+9.8%	$551.93M+8.0%	$545.45M+9.4%
Gross margin	79.3%+1.7pp	79.4%+3.7pp	79.2%+4.8pp	78.2%+4.1pp	77.6%+4.5pp
Research and development	$119.69M+35.0%	$116.96M+43.4%	$103.41M+34.0%	$96.54M+22.4%	$88.68M+14.6%
Selling, general and administrative	$375.93M+21.7%	$368.76M+25.4%	$346.77M+23.7%	$329.3M+20.2%	$308.85M+14.1%
Depreciation and amortization	$57.29M0.0%	$57.29M0.0%	$57.29M0.0%	$57.29M0.0%	$57.29M0.0%
Other operating expenses	——	——	——	——	——
Total costs & expenses	$710.76M-9.7%	$707.22M-8.7%	$675.24M-11.1%	$810.18M+35.5%	$787.37M+36.3%
Operating income	$24.1M—	$19.19M—	——	——	——
Operating margin	3.3%—	2.6%—	——	——	——
Interest expense	$16.57M-7.1%	$17.45M+5.3%	$18.23M+19.4%	$18.64M+32.7%	$17.83M+27.1%
Interest income	$17.77M-21.7%	$22.73M+15.5%	$25.99M+48.0%	$22.94M+54.6%	$22.68M+85.8%
Other income (expense), net	-$10.94M-166%	-$2.32M-123%	$274K-97.1%	-$2.22M-129%	$16.55M+710%
Income before income taxes	$13.17M—	$16.87M—	——	——	——
Income tax expense	——	——	$20.39M-43.1%	$20.91M-43.4%	$35.69M+13.9%
Net income	$5.14M—	$7.03M—	——	——	——
Net margin	0.7%—	1%—	——	——	——
Diluted earnings per share	$0.12—	$0.15—	——	——	——
Basic earnings per share	$0.12—	$0.15—	——	——	——
Weighted-average shares, diluted	175.9M-7.2%	181.5M-7.0%	182.7M-9.0%	184.4M-10.8%	189.4M-9.0%
Weighted-average shares, basic	174.5M-5.6%	180.3M-2.5%	182M-1.6%	184.1M-0.6%	184.8M-0.2%
Amortization of capitalized software and acquired intangible assets	$57.29M0.0%	$57.29M0.0%	$57.29M0.0%	$57.29M0.0%	$57.29M0.0%
Other income, net (Note 6)	-$11.16M-366%	-$6.62M-1,675%	-$6.5M—	-$6.51M—	$4.19M—
Other income, net	——	——	——	——	——
Revenue From Contract With Customer Excluding Assessed Tax	$734.86M+4.6%	$726.41M+3.6%	$716.79M+3.1%	$705.85M+2.3%	$702.77M+3.1%
EBIT	$24.1M—	$19.19M—	——	——	——
EBITDA	$115.29M—	$110.21M—	——	——	——
EBITDA	$115.29M—	$110.21M—	——	——	——
EBITDA margin	15.7%—	15.2%—	——	——	——
EBIT	$24.1M—	$19.19M—	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Pacira BioSciences, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Pacira BioSciences, Inc.'s revenue?: Pacira BioSciences, Inc. (PCRX) generated $734.9M in revenue over the trailing twelve months, up 4.6% year over year.
Is Pacira BioSciences, Inc. profitable?: Pacira BioSciences, Inc. reported $5.1M in net income over the trailing twelve months, a 0.7% net margin.
What are Pacira BioSciences, Inc.'s profit margins?: Gross margin is 79.3% and operating margin is 3.3%, with a 0.7% net margin.
What is Pacira BioSciences, Inc.'s earnings per share?: Pacira BioSciences, Inc.'s diluted EPS over the trailing twelve months is $0.12.
Where does Pacira BioSciences, Inc.'s income statement data come from?: Every line is extracted from Pacira BioSciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.